Implementing Active Assisted Living Technology in the Long-term Care of People Living With Dementia to Address Loneliness: European Survey.

Alzheimer CFIR active assisted living technology dementia implementation loneliness long-term care social isolation

Journal

JMIR aging
ISSN: 2561-7605
Titre abrégé: JMIR Aging
Pays: Canada
ID NLM: 101740387

Informations de publication

Date de publication:
14 Jun 2023
Historique:
received: 23 12 2022
accepted: 12 05 2023
revised: 21 02 2023
medline: 14 6 2023
pubmed: 14 6 2023
entrez: 14 6 2023
Statut: epublish

Résumé

In the lives of people with dementia, loneliness is an important issue with psychological and physical consequences. Active assisted living (AAL) technology has been gaining visibility in the care of persons living with dementia, including addressing loneliness. However, to the best of our knowledge, there is a lack of evidence concerning the factors influencing the implementation of AAL technology within the context of dementia, loneliness, and long-term care (LTC). We aimed to identify the familiarity with AAL technology that is promising for addressing loneliness in persons living with dementia in LTC in Europe and the factors influencing AAL technology implementation. A web-based survey was developed based on findings from our previous literature review. The Consolidated Framework for Implementation Research guided the development and analysis of the survey. Participants included 24 representatives of Alzheimer Europe member associations from 15 European countries. The data were analyzed using basic statistical methods (descriptive statistics). The baby seal robot Paro was reported to be the most familiar AAL technology by 19 of 24 participants addressing loneliness in people with dementia living in LTC. Participants from Norway (n=2) reported familiarity with 14 AAL technologies, and participants from Serbia (n=1) reported zero familiarity. It seems that countries that invest less in LTC facilities are familiar with fewer AAL technologies. At the same time, these countries report a more positive attitude toward AAL technology, express a higher need for it, and see more advantages than disadvantages than those countries that invest more in LTC. However, a country's investment in LTC facilities does not seem to be linked to other implementation aspects such as costs, planning, and the impact of infrastructure. Implementation of AAL technology to address loneliness in dementia seems to be linked to familiarity with the technology in a country as well as national investment in LTC facilities. This survey confirms the literature on higher investment countries' critical stance in regard to AAL technology implementation to address loneliness in persons living with dementia living in LTC. Further research is needed to clarify the potential reasons why familiarity with more AAL technology does not seem to be directly linked with acceptance, positive attitude, or satisfaction with AAL technology addressing loneliness in persons living with dementia.

Sections du résumé

BACKGROUND BACKGROUND
In the lives of people with dementia, loneliness is an important issue with psychological and physical consequences. Active assisted living (AAL) technology has been gaining visibility in the care of persons living with dementia, including addressing loneliness. However, to the best of our knowledge, there is a lack of evidence concerning the factors influencing the implementation of AAL technology within the context of dementia, loneliness, and long-term care (LTC).
OBJECTIVE OBJECTIVE
We aimed to identify the familiarity with AAL technology that is promising for addressing loneliness in persons living with dementia in LTC in Europe and the factors influencing AAL technology implementation.
METHODS METHODS
A web-based survey was developed based on findings from our previous literature review. The Consolidated Framework for Implementation Research guided the development and analysis of the survey. Participants included 24 representatives of Alzheimer Europe member associations from 15 European countries. The data were analyzed using basic statistical methods (descriptive statistics).
RESULTS RESULTS
The baby seal robot Paro was reported to be the most familiar AAL technology by 19 of 24 participants addressing loneliness in people with dementia living in LTC. Participants from Norway (n=2) reported familiarity with 14 AAL technologies, and participants from Serbia (n=1) reported zero familiarity. It seems that countries that invest less in LTC facilities are familiar with fewer AAL technologies. At the same time, these countries report a more positive attitude toward AAL technology, express a higher need for it, and see more advantages than disadvantages than those countries that invest more in LTC. However, a country's investment in LTC facilities does not seem to be linked to other implementation aspects such as costs, planning, and the impact of infrastructure.
CONCLUSIONS CONCLUSIONS
Implementation of AAL technology to address loneliness in dementia seems to be linked to familiarity with the technology in a country as well as national investment in LTC facilities. This survey confirms the literature on higher investment countries' critical stance in regard to AAL technology implementation to address loneliness in persons living with dementia living in LTC. Further research is needed to clarify the potential reasons why familiarity with more AAL technology does not seem to be directly linked with acceptance, positive attitude, or satisfaction with AAL technology addressing loneliness in persons living with dementia.

Identifiants

pubmed: 37314840
pii: v6i1e45231
doi: 10.2196/45231
pmc: PMC10334712
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e45231

Informations de copyright

©Kübra Beliz Budak, Franziska Laporte Uribe, Franka Meiland, Simone Anna Felding, Sonja Teupen, Johannes Michael Bergmann, Rene Mueller-Widmer, Martina Roes. Originally published in JMIR Aging (https://aging.jmir.org), 14.06.2023.

Références

Aging Ment Health. 2017 Jan;21(1):58-65
pubmed: 27936876
Implement Sci. 2016 May 17;11:72
pubmed: 27189233
J Gerontol A Biol Sci Med Sci. 2004 Mar;59(3):268-74
pubmed: 15031312
J Gerontol B Psychol Sci Soc Sci. 2020 Aug 13;75(7):1414-1422
pubmed: 30365023
BMC Geriatr. 2022 May 27;22(1):457
pubmed: 35624435
BMC Health Serv Res. 2022 Feb 1;22(1):136
pubmed: 35105344
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Aging Ment Health. 2014 Sep;18(7):809-14
pubmed: 24815025
Health Info Libr J. 2017 Mar;34(1):5-19
pubmed: 28191727
J Alzheimers Dis. 2017;56(4):1301-1340
pubmed: 28222516
Dementia (London). 2022 Apr;21(3):1012-1031
pubmed: 35152790
BMC Geriatr. 2020 Jan 28;20(1):27
pubmed: 31992217
Dementia (London). 2019 Feb;18(2):725-741
pubmed: 28178858
JMIR Rehabil Assist Technol. 2017 Jan 16;4(1):e1
pubmed: 28582262
Int J Environ Res Public Health. 2022 Feb 10;19(4):
pubmed: 35206143
JAMA Psychiatry. 2016 Dec 01;73(12):1230-1237
pubmed: 27806159
Disabil Rehabil Assist Technol. 2021 Nov 09;:1-13
pubmed: 34752177
J Med Internet Res. 2021 Dec 30;23(12):e28022
pubmed: 34967760
BMC Geriatr. 2021 Jun 9;21(1):351
pubmed: 34107876
Int Psychogeriatr. 2013 Jun;25(6):867-76
pubmed: 23425369
Implement Sci. 2017 Feb 28;12(1):27
pubmed: 28241770
BMC Public Health. 2020 Feb 14;20(1):129
pubmed: 32054474
Maturitas. 2019 Sep;127:55-63
pubmed: 31351521
J Med Internet Res. 2021 Dec 20;23(12):e26767
pubmed: 34932010
BMC Geriatr. 2019 Aug 23;19(1):232
pubmed: 31443636

Auteurs

Kübra Beliz Budak (KB)

Deutsches Zentrum für Neurodegenerative Erkrankungen e.V., site Witten, Witten, Germany.
Department of Nursing Science, Faculty of Health, University of Witten/Herdecke, Witten, Germany.

Franziska Laporte Uribe (F)

Deutsches Zentrum für Neurodegenerative Erkrankungen e.V., site Witten, Witten, Germany.
Department of Nursing Science, Faculty of Health, University of Witten/Herdecke, Witten, Germany.

Franka Meiland (F)

Department of Medicine for Older People, Amsterdam Public Health Research Institute, Vrije Universiteit Medical Center, Amsterdam, Netherlands.

Simone Anna Felding (SA)

Deutsches Zentrum für Neurodegenerative Erkrankungen e.V., site Witten, Witten, Germany.
Department of Nursing Science, Faculty of Health, University of Witten/Herdecke, Witten, Germany.

Sonja Teupen (S)

Deutsches Zentrum für Neurodegenerative Erkrankungen e.V., site Witten, Witten, Germany.
Department of Nursing Science, Faculty of Health, University of Witten/Herdecke, Witten, Germany.

Johannes Michael Bergmann (JM)

Deutsches Zentrum für Neurodegenerative Erkrankungen e.V., site Witten, Witten, Germany.
Department of Nursing Science, Faculty of Health, University of Witten/Herdecke, Witten, Germany.

Rene Mueller-Widmer (R)

Deutsches Zentrum für Neurodegenerative Erkrankungen e.V., site Witten, Witten, Germany.
Department of Nursing Science, Faculty of Health, University of Witten/Herdecke, Witten, Germany.

Martina Roes (M)

Deutsches Zentrum für Neurodegenerative Erkrankungen e.V., site Witten, Witten, Germany.
Department of Nursing Science, Faculty of Health, University of Witten/Herdecke, Witten, Germany.

Classifications MeSH